Hellenic Healthcare Single-Member Holdings SA made a mandatory takeover bid to acquire remaining 29.62% stake in Diagnostic and Therapeutic Center of Athens HYGEIA SA (ATSE:HYGEIA) for €86 million on November 12, 2018. As part of transaction, Hellenic Healthcare will acquire 90.5 million shares for €0.95 per share. Post the transaction, Hellenic Healthcare Single-Member Holdings SA will hold 100% stake. The offer has been approved by the Capital Market Commission. The acceptance period for the tender offer will start from December 27, 2018 till February 7, 2019. Euroxx Securities S.A. acted as financial advisor to Diagnostic and Therapeutic Center of Athens HYGEIA SA. Till the end of the initial period of the offer on February 7, 2019, 157 Shareholders accepted the tender offer, offering 3.74 million shares representing 1.22% of the capital of HYGEIA and up till the same date, Hellenic Healthcare acquired 75.96 million shares representing 24.84% of the capital through the Athens Exchange at the price same as under the offer. Upon the completion of the two, Hellenic Healthcare owned 294.88 million shares representing 96.45% of the capital of HYGEIA. Hellenic Healthcare will exercise its takeover right to demand the transfer of the remaining shares at a price per share equal to the offered consideration. Hellenic Healthcare will decide on whether to delist HYGEIA or not, after the approval from the HYGEIA shareholders. As on February 15, 2019, Hellenic Healthcare exercised its takeover right to takeover the remaining shares. The right concerned the buyout of the remaining 10.75 million shares.